$CYN
The company announced today (January 27th) that its autonomous trailer sales have tripled year-over-year in 2025, and revenue has increased by 347.74% in the past 12 months. It has also expanded its collaboration with NVIDIA on autonomous driving development.
2
553
My prediction was spot on! $BNAI surged from $6.29 to $31.98, a 408% increase, yielding a profit of over $58,000.
Our call went very smoothly.
I will post real-time trading alerts in the group!
📲wa.me/12135125558
💰DM "8" to join
$BATL $MBAI $SLGB $NAMM
$BNAI
On January 21, 2026, the company announced a $2.05 million AI licensing partnership with Valio Technologies to jointly expand into the African government and commercial markets.
628
$BATL
The company rapidly increased its production capacity by changing its midstream partners. This demonstrates the potential of its assets and is a direct catalyst for the recent stock price surge.
4
1,074
$BNAI
I think he succeeded. I've already shared $BNAI's latest goals and plans in the WhatsApp group.
Join here: wa.me/12135747583
💰DM "8" to join
$BNAI
On January 21, 2026, the company announced a $2.05 million AI licensing partnership with Valio Technologies to jointly expand into the African government and commercial markets.
1
528
$BNAI
On January 21, 2026, the company announced a $2.05 million AI licensing partnership with Valio Technologies to jointly expand into the African government and commercial markets.
$ROLR
The company signed a letter of intent with Crypto.com's North American subsidiary to launch prediction market products in the first quarter of 2026, covering areas such as finance, entertainment, and sports.
1
245
$AHMA
A convention and tourism services company headquartered in the UAE, focusing its business on the Middle East tourism and convention market, a region with significant growth potential.
2
935
$LUCY The company claims approximately 44% market share in the smart security glasses category on Amazon and possesses relevant safety certifications.
1
254
$ALMS exceeded my expectations! 💸💸💸💸💸💸
$ALMS For the treatment of plaque psoriasis and systemic lupus erythematosus, it has entered a pivotal Phase 3 clinical trial. Drug A-005 is a CNS-penetrating TYK2 inhibitor targeting neuroinflammatory diseases and also has the potential to be a "first-in-class" drug.
2
661
$CYCN Focuses on developing sGC stimulants for serious diseases. This collaboration with Medsteer, integrating its closed-loop anesthesia technology, aims to accelerate the development of CYC-126 and holds great potential!
1
403
$ALMS For the treatment of plaque psoriasis and systemic lupus erythematosus, it has entered a pivotal Phase 3 clinical trial. Drug A-005 is a CNS-penetrating TYK2 inhibitor targeting neuroinflammatory diseases and also has the potential to be a "first-in-class" drug.
HenrySmith retweeted
📌 كيف تتفاعل الأسواق مع التوترات الجيوسياسية بين أمريكا وفنزويلا ❓🤔
🛢 النفط: دعم للأسعار وتقلبات أعلى بسبب مخاوف الإمدادات.
🟡 الذهب: ارتفاع مع توجه المستثمرين للملاذات الآمنة.
📉 الأسهم: تذبذب عام، وضغط على القطاعات الحساسة للمخاطر.
💱 الدولار: ميل طفيف للصعود كملاذ آمن وقت التوتر.
🌍 الأسواق الناشئة: زيادة الحذر وخروج سيولة مؤقتًا.
🔍👀الخلاصة: التوتر يرفع المخاطر ويزيد التقلبات، دون صدمة كبيرة ما لم يتصاعد الحدث عسكريًا أو تُفرض عقوبات أوسع.
#سوق_الأسهم_السعودية
#تاسي_تداول
HenrySmith retweeted
رقم قياسي جديد السيولة ✋
وكالعادة بالريوس 🔻
السيولة في جلسة اليوم تسجل ادنى مستوياتها منذ اواخر عام 2018م بمقدار 1.594 مليار ريال , رغم اغلاق المؤشر بارتفاع +58.39 ✅
- كسرنا الرقم القياسي حق الاسبوع الماضي و 2019م 👎
- جلسة 30 ديسمبر 2018 سجلنا فيها 1.45 مليار ريال.
*امس كانت ليلة راس السنة والاجانب محتلفين 👻🤣 (شوفوا صفقات البنوك والقياديات بالمزاد)
$ASPC continues to rise! Congratulations to my WhatsApp group members who have all reaped substantial rewards under my guidance 💸💸💸💸💸💸
$ASPC is seeking acquisition targets, having previously merged with an ESG/materials technology company. A bio-antimicrobial technology company could be the catalyst for this deal, with significant upside potential!
1
338
$ASPC is seeking acquisition targets, having previously merged with an ESG/materials technology company. A bio-antimicrobial technology company could be the catalyst for this deal, with significant upside potential!
$ELOG On December 24, 2025, it was announced that its wholly-owned subsidiary had signed its first photovoltaic power generation project contract, with a total value of approximately US$6.04 million.
2
1,113
$INDP has entered into a clinical supply agreement with BeiGene to jointly evaluate the combination therapy of Decoy20 with the marketed PD-1 inhibitor tislelizumab. This provides the product with an important proof-of-concept opportunity and a potential value enhancement pathway
1
614
$HIHO
On December 23, the company announced that it had signed a letter of intent to acquire a 51% stake in Regent-Feinbau Adermann GmbH in Germany, with completion expected by the end of March 2026.
1
314























